June 10, 2019 Intelligence: Late Breaking Lab News

Share on facebook
Share on twitter
Share on linkedin
Share on print
Share on email

Digital pathology is coming in a big way to two regions in two different nations. In the United Kingdom, it was announced on May 30 that the North Tees and Hartlepool NHS Foundation in the north of England signed a five-year contract with Sectra of Linköping, Sweden. Sectra is to deliver a “regional digital pathology solution” in support of the Northern Cancer Alliance. The alliance is a consortium of 10 separate healthcare trusts in the region. Just a week earlier, Alverno Laboratories of Hammond, Ind., issued a press release about its agreement with Royal Philips of Amsterdam, The Netherlands, to implement Philips’ FDA-cleared digital pathology system across Alverno’s central laboratory and the 30 hospitals it serves in multiple midwestern states.

MORE ON: Regional Digital Pathology 

Different factors are driving the use of digital pathology in these two regions. In the United Kingdom, a shortage of histopathologists has made national headlines because of delays in reporting the results of diagnostic tests for cancer patients. Use of digital pathology is one strategy to shorten existing cancer test turnaround times. In the case of Alverno Laboratories, the clinical and business strategy is to integrate and standardize across all the hospitals and labs served by Alverno. Use of digital pathology is expected to help achieve those strategies across all sites.


  • Effective Sept., 2019, Douglas P. Clark, MD, will become the Chief Medical Officer of Tri-Core Reference Laboratories of Albuquerque, N.M. Clark is currently Chair of Pathology at the University of New Mexico School of Medicine and has served on TriCore’s Board of Directors since 2013. He has held positions at BioMarker Strategies and Johns Hopkins School of Medicine.
  • EverlyWell of Austin, Texas, announced that Frank S. Ong, MD, is its new Chief Medical Officer and Scientific Officer. EverlyWell describes itself as a consumer at-home lab testing company. EverlyWell just raised $50 million in capital. Ong formerly worked at Guardant Health, Roche, Diagnostics, NantHealth, Illumina, and Cedars Sinai Medical Center.
  • OncoCyte Corporation, Inc., of Alameda, Calif., hired Kim Dickinson, MD, to be Vice President of Clinical Operations. Prior to this position, Dickinson served at Biocare Medical, Roche Tissue Diagnostics, Laboratory Corporation of America, Esoteric Testing, Quest Diagnostics, Citrus Valley Medical Center, and Pioneer Hospital.

That’s all the insider intelligence for this report.
Look for the next briefing on Monday, July 1, 2019.

dark_daily_logoHave you caught the latest e-briefings from DARK Daily? If so, then you’d know about …

…the report of researchers at the University of Queensland disclosing the discovery of a universal biomarker that can identify cancer in various human cells in just 10 minutes with 90% accuracy. The study was published in the journal Nature Communications.

You can get the free DARK Daily e-briefings by signing up at www.darkdaily.com.


Leave a Reply


You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.